Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies.
Reuter, Gilles; NECHIFOR - POTORAC, Iulia; de Herdt, Carlienet al.
[en] [en] INTRODUCTION: Exogenous and endogenous sex hormones, especially Progesterone agonists, may be causally linked to meningioma progression. Cessation of treatment leads to stabilization or regression of Progestin-induced meningioma. In many cases, avoiding sex hormone therapy may be possible in the context of meningioma treatment. However, hormonal treatment is not always easily replaceable and concise real-world recommendations regarding sex hormones and meningioma are lacking.
MATERIAL AND METHODS: A combined effort was initiated between Neurosurgical, Gynaecological and Endocrinological societies of Belgium to gather relevant information regarding sex hormone therapies and meningioma. After complete literature review, consensual recommendations were established.
RESULTS: Collegial recommendations regarding sex hormones therapies and meningioma in the context of oral contraceptives, menopause hormonal treatment, fertility treatment, pregnancy and gender-affirming therapies are emitted and nuanced.
DISCUSSION AND CONCLUSION: Withdrawal and monitoring of sex hormone therapies are discussed in detail.A decision tree regarding Meningioma and Combined contraception, Progestin Contraception, Menopause Hormonal treatment, Progestin and Gender-affirming therapy is suggested.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Reuter, Gilles ; Université de Liège - ULiège > Département des sciences cliniques
NECHIFOR - POTORAC, Iulia ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'endocrinologie clinique
de Herdt, Carlien; Department of Endocrinology, UZ Antwerpen, Antwerpen, Belgium
Ameryckx, Linda; Department of Gynecology, UZ Antwerpen, Antwerpen, Belgium
Brichant, Géraldine ; Université de Liège - ULiège > Département des sciences cliniques
Froelich, Sébastien; Department of Neurosurgery, Hopital Lariboisiere, Paris, France
Baussart, Bertrand ; Department of Neurosurgery, Hopital Lariboisiere, Paris, France
De Vleeschouwer, Steven ; Department of Neurosurgery, UZ Leuven, Leuven, Belgium
Menovsky, Tomas; Department of Neurosurgery, UZ Antwerpen, Antwerpen, Belgium
Van Havenberghe, Tony; Department of Neurosurgery, ZAS, Antwerpen, Belgium
Finet, Patrice; Department of Neurosurgery, UCL Saint Luc, Brussels, Belgium
Bruneau, Michael ; Department of Neurosurgery, UZ Brussels, Brussels, Belgium
Pintiaux, Axelle ; Université de Liège - ULiège > Département des sciences cliniques
Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies.
Abdelzaher, E., El-Gendi, S., Yehya, A., Gowil, A.G., Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Br. J. Neurosurg. 25 (2010), 707–713, 10.3109/02688697.2010.522743.
Abedalthagafi, M., Bi, W.L., Aizer, A.A., Merrill, P.H., Brewster, R., Agarwalla, P.K., Listewnik, M.L., Dias-Santagata, D., Thorner, A.R., Van Hummelen, P., Brastianos, P.K., Reardon, D.A., Wen, P.Y., Al-Mefty, O., Ramkissoon, S., Folkerth, R.D., Ligon, K.L., Ligon, A.H., Alexander, B.M., Dunn, I.F., Beroukhim, R., Santagata, S., Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol. 18 (2016), 649–655, 10.1093/neuonc/nov316.
Agopiantz, M., Carnot, M., Denis, C., Martin, E., Gauchotte, G., Hormone receptor expression in meningiomas: a systematic review. Cancers, 15, 2023, 10.3390/cancers15030980.
Andersen, L., Friis, S., Hallas, J., Ravn, P., Schrøder, H.D., Gaist, D., Hormone replacement therapy increases the risk of cranial meningioma. European journal of cancer (Oxford, England : 1990) 49 (2013), 3303–3310, 10.1016/j.ejca.2013.05.026.
Baldi, I., Gruber, A., A, A., Berteaud, E., P, L., Huchet, A., Tourdias, T., Kantor, G., Maire, J.P., Vital, A., Loiseau, H., Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000–2007. Neuro Oncol. 13 (2011), 1370–1378, 10.1093/neuonc/nor120.
Banerjee, J., Pääkkö, E., Harila, M., Herva, R., Tuominen, J., Koivula, A., Lanning, M., Harila-Saari, A., Radiation-induced meningiomas: a shadow in the success story of childhood leukemia. Neuro Oncol. 11 (2009), 543–549, 10.1215/15228517-2008-122.
Barghouthi, T., Lemley, R., Figurelle, M., Bushnell, C., Chapter 6 - epidemiology of neurologic disease in pregnancy. Steegers, E.A.P., Cipolla, M.J., Miller, E.C., (eds.) Handbook of Clinical Neurology, vol. 171, 2020, Elsevier, 119–141, 10.1016/B978-0-444-64239-4.00006-0.
Benson, V.S., Kirichek, O., Beral, V., Green, J., Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysis. Int. J. Cancer 136 (2014), 2369–2377, 10.1002/ijc.29274.
Benson, V.S., Pirie, K., Green, J., Bull, D., Casabonne, D., Reeves, G.K., Beral, V., Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study. Int. J. Cancer 127 (2010), 1692–1698, 10.1002/ijc.25184.
Bernat, A.L., Bonnin, S., Labidi, M., Aldahak, N., Bresson, D., Bouazza, S., Froelich, S., Regression of giant olfactory groove meningioma and complete visual acuity recovery after discontinuation of cyproterone acetate. J. Ophthalmic Vis. Res. 13 (2018), 355–358, 10.4103/jovr.jovr_21_17.
Bernat, A.L., Oyama, K., Hamdi, S., Mandonnet, E., Vexiau, D., Pocard, M., George, B., Froelich, S., Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients. Acta Neurochir. 157 (2015), 1741–1746, 10.1007/s00701-015-2532-3.
Blitshteyn, S., Crook, J.E., Jaeckle, K.A., Is there an association between meningioma and hormone replacement therapy. J. Clin. Oncol. : official journal of the American Society of Clinical Oncology 26 (2008), 279–282, 10.1200/jco.2007.14.2133.
Caroli, E., Salvati, M., Giangaspero, F., Ferrante, L., Santoro, A., Intrameningioma metastasis as first clinical manifestation of occult primary breast carcinoma. Neurosurg. Rev. 29 (2006), 49–54, 10.1007/s10143-005-0395-4.
Carroll, R.S., Zhang, J., Dashner, K., Sar, M., Wilson, E.M., Black, P.M., Androgen receptor expression in meningiomas. J. Neurosurg. 82 (1995), 453–460, 10.3171/jns.1995.82.3.0453.
Cea-Soriano, L., Blenk, T., Wallander, M.-A., Rodríguez, L.A.G., Hormonal therapies and meningioma: is there a link?. Cancer epidemiology 36 (2011), 198–205, 10.1016/j.canep.2011.08.003.
Cebula, H., Pham, T.Q., Boyer, P., Froelich, S., Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient. Acta Neurochir. 152 (2010), 1955–1956, 10.1007/s00701-010-0787-2.
Claus, E.B., Calvocoressi, L., Bondy, M.L., Schildkraut, J.M., Wiemels, J.L., Wrensch, M., Family and personal medical history and risk of meningioma. J Neurosurg 115 (2011), 1072–1077, 10.3171/2011.6.Jns11129.
Claus, E.B., Calvocoressi, L., Bondy, M.L., Wrensch, M., Wiemels, J.L., Schildkraut, J.M., Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J. Neurosurg. 118 (2012), 649–656, 10.3171/2012.9.jns12811.
Cushing, H., Meningiomas arising from the tuberculum sellae with the syndrome of primary optic atrophy and bitemporal field defects combined with a normal sella turcica in a middle-aged person. Acta Neuropathol. 1:2 (1929), 168–206.
Custer, B., Longstreth, W.T. Jr., Phillips, L.E., Koepsell, T.D., Van Belle, G., Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer, 6, 2006, 152, 10.1186/1471-2407-6-152.
Custer, B., Longstreth, W.T., Phillips, L.E., Koepsell, T.D., van Belle, G., Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer, 6, 2006, 10.1186/1471-2407-6-152 152-152.
Degeneffe, A., De Maertelaer, V., De Witte, O., Lefranc, F., The association between meningioma and breast cancer: a systematic review and meta-analysis. JAMA Netw. Open, 6, 2023, e2318620, 10.1001/jamanetworkopen.2023.18620.
Devalckeneer, A., Aboukais, R., Bourgeois, P., De Witte, O., Racape, J., Caron, S., Perbet, R., Maurage, C.A., Lejeune, J.P., Preliminary report of patients with meningiomas exposed to Cyproterone Acetate, Nomegestrol Acetate and Chlormadinone Acetate - monocentric ongoing study on progestin related meningiomas. Clin. Neurol. Neurosurg., 210, 2021, 106959, 10.1016/j.clineuro.2021.106959.
Dolecek, T.A., Dressler, E.V., Thakkar, J.P., Liu, M., Al-Qaisi, A., Villano, J.L., Epidemiology of meningiomas post-public law 107-206: the benign brain tumor cancer registries amendment act. Cancer 121 (2015), 2400–2410, 10.1002/cncr.29379.
Dresser, L., Yuen, C., Wilmington, A., Walker, M.T., Vogel, T.J., Merrell, R., Kamson, D.O., Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis. Sci. Rep., 10, 2020, 10.1038/s41598-020-74344-x 17960-17960.
Dumitrescu, B.C., Tataranu, L.G., Gorgan, M.R., Pregnant woman with an intracranial meningioma: case report and review of the literature. Romanian Neurosurgery, 2014, 482–489.
Fan, Z., Shen, J., Wu, Y., Yu, H., Zhu, Y., Zhan, R., Hormone replacement therapy and risk of meningioma in women: a meta-analysis. Cancer causes & control : CCC (Cancer Causes Control) 24 (2013), 1517–1525, 10.1007/s10552-013-0228-7.
Francois, P., N'Dri, D., Bergemer-Fouquet, A.M., Ben Ismail, M., Papagiannaki, C., Cottier, J.P., Jan, M., Post-traumatic meningioma: three case reports of this rare condition and a review of the literature. Acta Neurochir. 152 (2010), 1755–1760, 10.1007/s00701-010-0730-6.
Gazzeri, R., Galarza, M., Gazzeri, G., Growth of a meningioma in a transsexual patient after estrogen-progestin therapy. N. Engl. J. Med. 357 (2007), 2411–2412, 10.1056/nejmc071938.
Gil, M., Oliva, B., Timoner, J., Maciá, M.A., Bryant, V., de Abajo, F.J., Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study. Br. J. Clin. Pharmacol. 72 (2011), 965–968, 10.1111/j.1365-2125.2011.04031.x.
Gonçalves, A., Page, P., Domigo, V., Meder, J.F., Oppenheim, C., Abrupt regression of a meningioma after discontinuation of cyproterone treatment. AJNR American journal of neuroradiology 31 (2010), 1504–1505, 10.3174/ajnr.a1978.
Graillon, T., Boissonneau, S., Appay, R., Boucekine, M., Peyrière, H., Meyer, M., Farah, K., Albarel, F., Morange, I., Castinetti, F., Brue, T., Fuentes, S., Figarella-Branger, D., Cuny, T., Dufour, H., Meningiomas in patients with long-term exposition to progestins: characteristics and outcome. Neurochirurgie 67 (2021), 556–563, 10.1016/j.neuchi.2021.04.018.
Green, J., Reeves, G.K., Floud, S., Barnes, I., Cairns, B.J., Gathani, T., Pirie, K., Sweetland, S., Yang, T.O., Beral, V., Cohort profile: the million women study. Int. J. Epidemiol. 48 (2019), 28–29e, 10.1093/ije/dyy065.
Hage, M., Plesa, O., Lemaire, I., Raffin Sanson, M.L., Estrogen and progesterone therapy and meningiomas. Endocrinology, 163, 2021, 10.1210/endocr/bqab259.
Hatch, E.E., Linet, M.S., Zhang, J., Fine, H.A., Shapiro, W.R., Selker, R.G., Black, P.M., Inskip, P.D., Reproductive and hormonal factors and risk of brain tumors in adult females. Int. J. Cancer 114 (2005), 797–805, 10.1002/ijc.20776.
Hatch, E.E., Linet, M.S., Zhang, J., Fine, H.A., Shapiro, W.R., Selker, R.G., Black, P.M., Inskip, P.D., Reproductive and hormonal factors and risk of brain tumors in adult females. Int. J. Cancer 114 (2005), 797–805, 10.1002/ijc.20776.
Hoisnard, L., Laanani, M., Passeri, T., Duranteau, L., Coste, J., Zureik, M., Froelich, S., Weill, A., Risk of intracranial meningioma with three potent progestogens: a population-based case-control study. Eur. J. Neurol. 29 (2022), 2801–2809, 10.1111/ene.15423.
Hsu, D.W., Efird, J.T., Whyte Et, Hedley, Progesterone and estrogen receptors in meningiomas: prognostic considerations. J. Neurosurg. 86 (1997), 113–120, 10.3171/jns.1997.86.1.0113.
Hua, L., Zhu, H., Li, J., Tang, H., Kuang, D., Wang, Y., Tang, F., Chen, X., Zhou, L., Xie, Q., Gong, Y., Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution. J. Neurosurg. 128 (2017), 1698–1706, 10.3171/2017.2.jns162566.
Jhawar, B.S., Fuchs, C.S., Colditz, G.A., Stampfer, M.J., Sex steroid hormone exposures and risk for meningioma. J. Neurosurg. 99 (2003), 848–853, 10.3171/jns.2003.99.5.0848.
Johnson, D.R., Olson, J.E., Vierkant, R.A., Hammack, J.E., Wang, A.H., Folsom, A.R., Virnig, B.A., Cerhan, J.R., Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study. Neuro Oncol. 13 (2011), 1011–1019, 10.1093/neuonc/nor081.
Kalamarides, M., Peyre, M., Dramatic shrinkage with reduced vascularization of large meningiomas after cessation of progestin treatment. World Neurosurg, 101, 2017, 10.1016/j.wneu.2017.03.013 814.e817-814.e810.
Kerr, K., Qualmann, K., Esquenazi, Y., Hagan, J., Kim, D.H., Familial syndromes involving meningiomas provide mechanistic insight into sporadic disease. Neurosurgery 83 (2018), 1107–1118, 10.1093/neuros/nyy121.
Kerschbaumer, J., Freyschlag, C.F., Stockhammer, G., Taucher, S., Maier, H., Thomé, C., Seiz-Rosenhagen, M., Hormone-dependent shrinkage of a sphenoid wing meningioma after pregnancy: case report. J. Neurosurg. 124 (2015), 137–140, 10.3171/2014.12.jns142112.
Khazanchi, R., Nandoliya, K.R., Shahin, M.N., Rae, A.I., Chaliparambil, R.K., Bowden, S.G., Alwakeal, A., Lopez Ramos, C.G., Stedelin, B., Youngblood, M.W., Chandler, J.P., Lukas, R.V., Sanusi, O.R., Dogan, A., Wood, M.D., Han, S.J., Magill, S.T., Obesity and meningioma: a US population-based study paired with analysis of a multi-institutional cohort. J. Neurosurg. 140 (2024), 1558–1567, 10.3171/2023.11.JNS23732.
Khazanchi, R., Nandoliya, K.R., Shahin, M.N., Rae, A.I., Chaliparambil, R.K., Bowden, S.G., Alwakeal, A., Lopez Ramos, C.G., Stedelin, B., Youngblood, M.W., Chandler, J.P., Lukas, R.V., Sanusi, O.R., Dogan, A., Wood, M.D., Han, S.J., Magill, S.T., Obesity and meningioma: a US population-based study paired with analysis of a multi-institutional cohort. J Neurosurg, 2024, 1–10, 10.3171/2023.11.Jns23732.
Klaeboe, L., Lönn, S., Scheie, D., Auvinen, A., Christensen, H.C., Feychting, M., Johansen, C., Salminen, T., Tynes, T., Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968–1997. Int. J. Cancer 117 (2005), 996–1001, 10.1002/ijc.21255.
Korhonen, K., Auvinen, A., Lyytinen, H., Ylikorkala, O., Pukkala, E., A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland. Am. J. Epidemiol. 175 (2012), 309–314, 10.1093/aje/kwr335.
Korhonen, K., Raitanen, J., Isola, J., Haapasalo, H., Salminen, T., Auvinen, A., Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland. Cancer causes & control : CCC (Cancer Causes Control) 21 (2010), 2149–2156, 10.1007/s10552-010-9634-2.
Korhonen, K., Salminen, T., Raitanen, J., Auvinen, A., Isola, J., Haapasalo, H., Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. Journal of neuro-oncology 80 (2006), 1–7, 10.1007/s11060-006-9146-9.
Lee, A., Wallace, C., Rewcastle, B., Sutherland, G., Metastases to meningioma. AJNR Am J Neuroradiol 19 (1998), 1120–1122.
Lee, E., Grutsch, J., Persky, V., Glick, R.P., Mendes, J., Davis, F.G., Association of meningioma with reproductive factors. Int. J. Cancer 119 (2006), 1152–1157, 10.1002/ijc.21950.
Liu, F., Wei, C., Chen, J., Letter to the Editor. Is there any relationship between estrogen receptor/progesterone receptor status and recurrence of meningioma?. J. Neurosurg. 128 (2018), 1899–1901, 10.3171/2017.9.jns172219.
Lopez-Rivera, V., Zhu, P., Dono, A., Lee, S., Chen, P.R., Ballester, L.Y., Sheth, S.A., Esquenazi, Y., Increased risk of subsequent meningioma among women with malignant breast cancer. World Neurosurg 139 (2020), e271–e285, 10.1016/j.wneu.2020.03.203.
Louis, D.N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W.K., Ohgaki, H., Wiestler, O.D., Kleihues, P., Ellison, D.W., The 2016 world Health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131 (2016), 803–820, 10.1007/s00401-016-1545-1.
Lusis, E.A., Scheithauer, B.W., Yachnis, A.T., Fischer, B.R., Chicoine, M.R., Paulus, W., Perry, A., Meningiomas in pregnancy: a clinicopathologic study of 17 cases. Neurosurgery 71 (2012), 951–961, 10.1227/neu.0b013e31826adf65.
Malaizé, H., Samoyeau, T., Zanello, M., Roux, A., Benzakoun, J., Peeters, S., Zah-Bi, G., Edjlali, M., Tauziède-Espariat, A., Dezamis, E., Parraga, E., Chrétien, F., Varlet, P., Plu-Bureau, G., Oppenheim, C., Pallud, J., Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience. Journal of neuro-oncology 152 (2021), 279–288, 10.1007/s11060-021-03696-9.
Michaud, D.S., Gallo, V., Schlehofer, B., Tjønneland, A., Olsen, A., Overvad, K., Dahm, C.C., Kaaks, R., Lukanova, A., Boeing, H., Schütze, M., Trichopoulou, A., Bamia, C., Kyrozis, A., Sacerdote, C., Agnoli, C., Palli, D., Tumino, R., Mattiello, A., Bueno-de-Mesquita, H.B., Ros, M.M., Peeters, P.H.M., van Gils, C.H., Lund, E., Bakken, K., Gram, I.T., Barricarte, A., Navarro, C., Dorronsoro, M., Sánchez, M.J., Rodríguez, L., Duell, E.J., Hallmans, G., Melin, B., Manjer, J., Borgquist, S., Khaw, K.-T., Wareham, N.J., Allen, N.E., Tsilidis, K.K., Romieu, I., Rinaldi, S., Vineis, P., Riboli, E., Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 19 (2010), 2562–2569, 10.1158/1055-9965.epi-10-0447.
Miller, R.E., Breast cancer and meningioma. J. Surg. Oncol. 31 (1986), 182–183, 10.1002/jso.2930310309.
Millward, C.P., Keshwara, S.M., Islim, A.I., Jenkinson, M.D., Alalade, A.F., Gilkes, C.E., Development and growth of intracranial meningiomas in transgender women taking cyproterone acetate as gender-affirming progestogen therapy: a systematic review. Transgend Health 7 (2022), 473–483, 10.1089/trgh.2021.0025.
Millward, C.P., Phillips, E., Alalade, A.F., Gilkes, C.E., Gender-affirming hormone therapy associated with multiple meningiomas and atypical histology in a transgender woman. BMJ Case Rep., 14, 2021, 10.1136/bcr-2021-242813.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, 2009, b2535, 10.1136/bmj.b2535.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg. 8 (2010), 336–341, 10.1016/j.ijsu.2010.02.007.
Ostrom, Q.T., Gittleman, H., Truitt, G., Boscia, A., Kruchko, C., Barnholtz-Sloan, J.S., CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro Oncol. 20 (2018), iv1–iv86, 10.1093/neuonc/noy131.
Passeri, T., Champagne, P.O., Bernat, A.L., Hanakita, S., Salle, H., Mandonnet, E., Froelich, S., Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients. Acta Neurochir. 161 (2019), 761–765, 10.1007/s00701-019-03848-x.
Patterson, A., Elashaal, A., Fast-growing meningioma in a woman undergoing fertility treatments. Case Reports in Neurological Medicine, 2016, 2016, 3287381, 10.1155/2016/3287381.
Portet, S., Banor, T., Bousquet, J., Simonneau, A., Flores, M., Ingrand, P., Milin, S., Karayan-Tapon, L., Bataille, B., New insights into expression of hormonal receptors by meningiomas. World Neurosurg 140 (2020), e87–e96, 10.1016/j.wneu.2020.04.168.
Pravdenkova, S., Al-Mefty, O., Sawyer, J.R., Husain, M., Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J. Neurosurg. 105 (2006), 163–173, 10.3171/jns.2006.105.2.163.
Prince, J.C.J., Safer, J.D., Endocrine treatment of transgender individuals: current guidelines and strategies. Expet Rev. Endocrinol. Metabol. 15 (2020), 395–403, 10.1080/17446651.2020.1825075.
Qi, Z., Shao, C., Huang, Y., Hui, G.-Z., Zhou, Y.-X., Wang, Z., Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis. PLoS One, 8, 2013, e83261, 10.1371/journal.pone.0083261 NA.
Rao, G., Giordano, S.H., Liu, J., McCutcheon, I.E., The association of breast cancer and meningioma in men and women. Neurosurgery 65 (2009), 483–489, 10.1227/01.Neu.0000350876.91495.E0 ; discussion 489.
Rogers, L., Barani, I.J., Chamberlain, M.C., Kaley, T., McDermott, M.W., Raizer, J., Schiff, D., Weber, D.C., Wen, P.Y., Vogelbaum, M.A., Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J. Neurosurg. 122 (2015), 4–23, 10.3171/2014.7.jns131644.
Roland, N.N.A., Hoisnard, L., Zureik, M., Weill, A., Utilisation de progestatifs et risque de méningiome intracrânien :une étude cas-témoins à partir des données du système national des données de santé (SNDS) wwwepi-pharefr. 2023.
Roser, F., Nakamura, M., Bellinzona, M., Rosahl, S.K., Ostertag, H., Samii, M., The prognostic value of progesterone receptor status in meningiomas. J. Clin. Pathol. 57 (2004), 1033–1037, 10.1136/jcp.2004.018333.
Samarut, E., Lugat, A., Amelot, A., Scharbarg, E., Hadjadj, S., Primot, C., Loussouarn, D., Thillays, F., Buffenoir, K., Cariou, B., Drui, D., Roualdes, V., Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma. Journal of neuro-oncology 152 (2021), 115–123, 10.1007/s11060-020-03683-6.
Sehgal, I., Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations. Front. Endocrinol., 14, 2023, 1184024, 10.3389/fendo.2023.1184024.
Shah, D.S., Sanan, A., Morell, A.A., Eichberg, D.G., Shah, A.H., Luther, E., Lu, V.M., Elarjani, T., Higgins, D.M.O., Patel, N.V., Jagid, J.R., Ivan, M.E., Komotar, R.J., Traumatic brain injury and subsequent brain tumor development: a systematic review of the literature. Neurosurg. Rev. 45 (2022), 3003–3018, 10.1007/s10143-022-01819-y.
Shu, X., Jiang, Y., Wen, T., Lu, S., Yao, L., Meng, F., Association of hormone replacement therapy with increased risk of meningioma in women: a hospital-based multicenter study with propensity score matching. Asia Pac. J. Clin. Oncol. 15 (2019), e147–e153, 10.1111/ajco.13138.
Takei, H., Buckleair, L.W., Powell, S.Z.-E., Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas. Neuropathology : official journal of the Japanese Society of Neuropathology 28 (2007), 62–68, 10.1111/j.1440-1789.2007.00852.x.
Turner, N., Kaye, A.H., Paldor, I., Metastases to meningioma-review and meta-analysis. Acta Neurochir. 163 (2021), 699–709, 10.1007/s00701-020-04661-7.
Vernooij, M.W., Ikram, M.A., Tanghe, H.L., Vincent, A.J., Hofman, A., Krestin, G.P., Niessen, W.J., Breteler, M.M., van der Lugt, A., Incidental findings on brain MRI in the general population. N. Engl. J. Med. 357 (2007), 1821–1828, 10.1056/NEJMoa070972.
Voormolen, E.H.J., Champagne, P.O., Roca, E., Giammattei, L., Passeri, T., di Russo, P., Sanchez, M.M., Bernat, A.L., Yoldjian, I., Fontanel, S., Weill, A., Mandonnet, E., Froelich, S., Intracranial meningiomas decrease in volume on magnetic resonance imaging after discontinuing progestin. Neurosurgery 89 (2021), 308–314, 10.1093/neuros/nyab175.
Weill, A., Nguyen, P., Labidi, M., Cadier, B., Passeri, T., Duranteau, L., Bernat, A.-L., Yoldjian, I., Fontanel, S., Froelich, S., Coste, J., Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study. BMJ (Clinical research ed) 372 (2021), n37–NA, 10.1136/bmj.n37.
Wiemels, J., Wrensch, M., Claus, E.B., Epidemiology and etiology of meningioma. J. Neuro Oncol. 99 (2010), 307–314, 10.1007/s11060-010-0386-3.
Wiemels, J.L., Wrensch, M., Claus, E.B., Epidemiology and etiology of meningioma. Journal of neuro-oncology 99 (2010), 307–314, 10.1007/s11060-010-0386-3.
Wigertz, A., Lönn, S., Mathiesen, T., Ahlbom, A., Hall, P., Feychting, M., Risk of brain tumors associated with exposure to exogenous female sex hormones. Am. J. Epidemiol. 164 (2006), 629–636, 10.1093/aje/kwj254.
Yamada, S., Hirayama, R., Iwata, T., Kuroda, H., Nakagawa, T., Takenaka, T., Kijima, N., Okita, Y., Kagawa, N., Kishima, H., Growth risk classification and typical growth speed of convexity, parasagittal, and falx meningiomas: a retrospective cohort study. J Neurosurg 138 (2023), 1235–1241, 10.3171/2022.8.Jns221290.
Yamanaka, R., Hayano, A., Kanayama, T., Radiation-induced meningiomas: an exhaustive review of the literature. World Neurosurg 97 (2017), 635–644.e638, 10.1016/j.wneu.2016.09.094.
Yang, X., Liu, F., Zheng, J., Cheng, W., Zhao, C., Di, J., Relationship between oral contraceptives and the risk of gliomas and meningiomas: a dose-response meta-analysis and systematic review. World Neurosurg 147 (2020), e148–e162, 10.1016/j.wneu.2020.11.175.
